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DexmedetomidineAbstract Introduction: Parkinson’s disease (PD) is a severe, debilitating disease of the extra pyra-
midal central nervous system, which has a significant effect on lifestyle and day to day living of the
affected population. Statistically, more of the elderly are now going to present with this disease.
Moving ahead from older procedures such as cingulotomy, pallidotomy and thalamotomy which
had irreversible side effects, deep brain stimulation (DBS) has emerged as a new, safer and more
attractive option for such patients. Anaesthetic concerns for such procedures mainly incorporate
principles of awake craniotomy, for which the basic requirement is a cooperative patient. Although
Propofol was somewhat of a gold standard for this purpose until a few years back, Dexmedeto-
midine has emerged as the new drug of choice.
Case: While conducting two surgeries for DBS over two days, we had an obverse experience with
these drugs. We describe the pre-operative assessment and intra-operative management of the two
cases and a discussion of the factors which might have contributed to this contradiction.
Conclusion: The choice of sedation for DBS in PD should take into consideration factors such as
patient cooperation, ‘drug off’ state due to pre-op medication stoppage, GABA versus non-GABA
mediated mechanism of drugs, amount of dependence on PD drugs, severity of disease and finally
requirement of the testing team. No drug can be singled out to be better and must be chosen based
on individual merits of the patient and disease.
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2 M. Dhar et al.1. Introduction
Parkinson’s disease (PD) is a severe, debilitating disease of the
extra pyramidal central nervous system, which has a significant
effect on lifestyle and day to day living of the affected popula-
tion. Statistically, more of the elderly are now going to present
with this disease [1,2]. Moving ahead from older procedures
such as cingulotomy, pallidotomy and thalamotomy which
had irreversible side effects [1,3], deep brain stimulation
(DBS) has emerged as a new, safer and more attractive option
for such patients. Anaesthetic concerns for such procedures
mainly incorporate principles of awake craniotomy, for which
the basic requirement is a cooperative patient. Most common
mode employed is conscious sedation or monitored anaesthe-
sia care (MAC) supplemented with local anaesthesia (LA).
Although Propofol was somewhat of a gold standard for this
purpose until a few years back, Dexmedetomidine has emerged
as the new drug of choice [1,3–5]. While conducting two surg-
eries for DBS over two days, we had an obverse experience
with these drugs. Describing the peri-operative evaluation
and management of the two cases and a discussion of the fac-
tors might have contributed to this contradiction.
2. Case 1
A 45 year old, 50 kg male was listed for deep brain stimulation
for his Parkinson’s of 5 years duration. On pre anaesthetic
evaluation and history there were no other co-morbidities. Air-
way examination was essentially normal with adequate mouth
opening and neck movements. His medication list included
oral Carbidopa-Levodopa (CL) 25/100 mg TDS, Ropinirole
5 mg TDS and Trihexyphenidyl 2 mg TDS, with history of
good compliance. Although his symptoms were relatively well
controlled with the medication, his drug requirement was
increasing. This was chosen for DBS surgery, in an effort to
tone down the medication. He was evaluated and counselled
by the anaesthesiologist and the surgeon along with a psycho-
logical evaluation to rule out claustrophobia and other issues
which might affect the intra-operative course. He seemed moti-
vated and enthusiastic about the procedure. He was advised
about pre-operative fasting and aspiration prophylaxis and
asked to omit the PD medication. He was planned for a bilat-
eral electrode placement and pulse generator placement in a
single sitting.
On the morning of surgery, the difference in symptoms due
to omission of drugs was quite striking as he was almost bed
ridded compared to his mobility of the previous evening. But
he was able to cough and maintain his airway. He was first
taken to the MRI suite where a stereotactic frame was applied
with local anaesthetic infiltration. He was later wheeled into
the theatre, while continuously explaining the whole process
and encouraging him for the long procedure which lay ahead.
After applying standard monitors in the form of ECG, pulse
oximetry and non invasive blood pressure, the neurologist
tested the baseline tone and power of the muscles, following
which an infusion of Propofol was initiated (25 mcg/kg/min)
aimed at conscious sedation. A burr hole was created after
local anaesthetic infiltration and electrode placement was loca-
lized using neuro-physiological testing. 10–15 min before clin-
ical testing the propofol infusion was stopped and the patient
awakened. The same was repeated on the contra-lateral sidePlease cite this article in press as: Dhar M et al. Choice of sedative for deep brain st
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out the whole process patient was given oxygen via nasal
prongs, and there were no airway related incidents. Although
a long and tedious procedure lasting almost 6 h, the patient
was quite comfortable. Finally general anaesthesia was
induced with endo-tracheal intubation for tunnelling of pulse
generator. The patient was extubated on table after adequate
clinical and neuro-muscular recovery and shifted to ICU for
monitoring.
3. Case 2
A 58 year old, 75 kg male PD patient was evaluated in the pre-
anaesthetic check-up. He had history of hypertension for the
past 5 years on Amlodipine 5 mg BD. He was also on CL
25/100 mg BD, Ropinirole 2.5 mg TDS and Selegiline 5 mg
OD for his PD since the past 2 years. His symptoms had been
gradually worsening with his current medication with increas-
ing dyskinesia and motor fluctuations. He was thus planned
for DBS to control his worsening symptoms. A similar psycho-
logical review along with counselling by all the physicians
involved was done. The patient although apprehensive
initially, after explaining the process in detail, along with the
merits and demerits of the procedure agreed to go ahead with
it. Air way examination revealed no significant findings or any
history suggestive of obstructed sleep apnoea or any respira-
tory issues, although patient was slightly overweight
(BMI = 28 kg/m2). The patient was asked to take half dose
of his PD medication on day of surgery and was advised anx-
iolysis the evening prior.
The MRI suite and initial theatre procedures were unevent-
ful. As the patient was overweight and there was a slight risk of
airway compromise we decided to start Dexmedetomidine
(1 mcg/kg slow loading dose followed by 0.5 mcg/kg/min infu-
sion). The drug seemed to work smoothly for the initial part of
the procedure with good patient acceptance. But after starting
the procedure on the contra-lateral side the patient started to
become fidgety and restless. Slight titrated increase in sedation
did not improve the situation. As the neuro-physiological test-
ing procedure was almost nearing completion the team decided
to go ahead with the procedure and patient was switched to
Propofol infusion for the remainder of the time. This time a
slightly heavier sedation dose is required (75 mcg/kg/min), as
we had almost completely lost the patient’s cooperation at
the fag end of the procedure. Ultimately the patient was intu-
bated for the last tunnelling procedure and was shifted to ICU
after appropriate neuro-muscular recovery and extubation.
4. Discussion
The non-pharmacological treatment of PD has gradually
evolved from more gross, destructive procedures such as thala-
motomy and pallidotomy to more refined and precise proce-
dures such as DBS and gamma knife surgery [1,3]. DBS was
first described in 1987 for PD and is now being used for other
movement disorders such as dystonias, essential tremors and
also some psychiatric conditions [1,3,6]. The attractive feature
of DBS is its reversibility and ability to titrate the dose of stim-
ulation [1]. The target areas of the brain for stimulation in PD
mainly include the Subthalamic nucleus and the Globus Pal-
lidus [1,7].imulation in Parkinson’s disease: Our experience and comparison of two cases,
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and clinical testing guided positioning of stimulating electrodes
and internalization of the impulse generator either in a single
or a staged sitting. The decision of single or staged procedure
and unilateral or bilateral procedure is guided by factors such
as duration of procedure, expertise of surgeon, availability of
associated specialists such as neurologists and most impor-
tantly, and patient cooperation [1,3].
Pre-anaesthetic assessment of such patients includes evalu-
ation of disease severity, co-existing diseases especially obesity
and sleep apnoea, drug interactions and patient dependence on
the drugs [3,8]. Airway assessment is of special importance as
on most occasions the airway is inaccessible due to the stereo-
tactic frame which is applied before the procedure for radio-
logical localization of brain areas. Also, there might be associ-
ated cranial nerve involvement hampering maintenance of a
patent airway under sedation or anaesthesia. Such patients
may also have autonomic disturbances. As mentioned above,
a thorough multi-disciplinary evaluation and appropriate
counselling pre-procedure are prudent.
Intra-operative concerns are regarding the type of anaesthe-
sia to be given which mainly includes conscious sedation
(MAC), Total intra venous anaesthesia (TIVA) or only LA.
The other aspect involves the choice of anaesthetic agent to
be used for this purpose.
General consensus puts Benzodiazepines out of contention
due to its established effects on micro electrode recordings
(MER) and interference with localization during testing [1,3].
Propofol has been a standard drug for procedures under
TIVA, owing to its predictable pharmacokinetics (PK) and
clear headed and swift recovery. But its use is slightly tricky
in PD patients as its PK is different in this context. Mean infu-
sion rates of 50 mcg/kg/mi have been described for this pur-
pose based on traditional target controlled infusion models
[3,9]. Its effect on MER is still doubtful. But it causes dyski-
netic effects and also abolishes tremors which is an undesirable
feature in such procedures [3]. Dexmedetomidine in a dose of
0.3–0.6 mcg/kg/min seems to a better choice owing to its non
GABA-minergic mechanism of action [3–5]. Thus, it adds to
the hemodynamic stability, has minimal effect on the MER
and allows better clinical testing.
The literature thus suggests a slight upper hand in favour of
Dexmedetomidine. In our two cases the first younger patient
who was managed with a propofol infusion had a well con-
trolled and stable PD. He did not have any co-morbidities
and was extremely cooperative and compliant. The second case
managed with Dexmedetomidine, was a more elderly hyper-
tensive patient who was on numerous drugs, was overweight,
was slightly apprehensive and had an ill controlled disease.
Thus it was advised against complete stoppage of PD drug
pre procedure. Propofol, in our cases seemed to be a better
choice mostly in terms of patient comfort taking into consider-
ation the described factors. Dexmedetomidine although patho-
physiology wise a better choice, was not as effective alone. A
few reports have described its use in combination with inter-
mittent propofol, as was done in our second case [10].
A final mention must be made of the importance of having
a backup emergency airway plan and related equipments, espe-Please cite this article in press as: Dhar M et al. Choice of sedative for deep brain st
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airway emergency [3].
5. Conclusion
Propofol has been conventionally used and has the advantage
of familiarity of use but unpredictable effect on neurophysio-
logical testing. Dexmedetomidine is theoretically a better
option for testing and patient comfort, but may sometimes
not be as effective alone. The choice of sedation for DBS in
PD should take into consideration the factors such as patient
cooperation, ‘drug off’ state due to pre-op medication stop-
page, GABA versus non GABA-minergic mechanism of drugs,
amount of dependence on PD drugs, severity of disease and
finally requirement of the testing team. No drug can be singled
out to be better and must be chosen based on individual merits
of the patient and disease.
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